E. M. Scanlan et al.
the same conditions as Group 1. The cells were allowed to recover for
four hours in the dark at 378C and 5% CO2 in a humidified atmosphere.
Acta 1991, 1071, 1–18; d) T. Irimura, Y. Matsushita, R. C. Sutton,
E. D. Carralero, D. W. Ohannesian, K. R. Cleary, D. M. Ota, G. L.
Nicolson, R. Lotan, Cancer Res. 1991, 51, 387–393.
Cell proliferation assay: Two plates (one illuminated and one non-illumi-
nated) were used for a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoli-
um bromide (MTT) assay (Promega, USA), according to manufacturerꢀs
instructions.[40] Immediately following illumination, MTT dye (15 mL) was
added to each well and the plates were kept for four hours at 378C and
5% CO2 in a humidified atmosphere in the dark. The formatazan crystals
were allowed to dissolve overnight at room temperature and absorbance
was measured at 540 nm with a Wallac Victor2 plate reader (Perkin–
Elmer, Singapore).
[6] a) B. C. Wilson, M. S. Patterson, Phys. Med. Biol. 2008, 53, 61–109;
b) J. P. Celli, B. Q. Spring, I. Rizvi, C. L. Evans, K. S. Samkoe, S.
[7] a) O. B. Locos, C. C. Heindl, A. Corral, M. O. Senge, E. M. Scanlan,
Daly, V. Ahsen, E. M. Scanlan, A. S. P. Lavado, J. W. Aylott, G. A.
[8] For reviews, see: a) J. A. S. Cavaleiro, J. P. C. Tomꢃ, M. A. F. Fausti-
231; c) S. Silva, P. M. R. Pereira, P. Silva, F. A. A. Paz, M. A. F. Faus-
[9] a) I. Sylvain, R. Zerrouki, R. Granet, Y. M. Huang, J. F. Lagorce, M.
69; b) X. Chen, C. M. Drain, Drug Des. Rev.—Online 2004, 1, 215–
234; c) I. Laville, S. Pigaglio, J. C. Blais, F. Doz, B. Loock, P. Mail-
d) S. Hirohara, M. Nishida, K. Sharyo, M. Obata, T. Ando, M. Tani-
[10] a) C. F. Choi, J. D. Huang, P. C. Lo, W.-P. Fong, D. K. P. Ng, Org.
Soares, M. G. P. M. S. Neves, A. C. Tomꢃ, M. C. Iglesias-de la Cruz,
A. Zamarron, E. Carrasco, S. Gonzalez, J. A. S. Cavaleiro, T. Torres,
[11] a) G. Zheng, A. Graham, M. Shibata, J. R. Missert, A. R. Oseroff,
b) G. Li, S. K. Pandey, A. Graham, M. P. Dobhal, R. Mehta, Y.
Chen, A. Gryshuk, K. Rittenhouse-Olson, A. Oseroff, R. K. Pandey,
Thompson, J. P. C. Tomꢃ, X. Zhu, D. Samaroo, M. Vinodu, R. Gao,
High content imaging and analysis for uptake studies: After 0, 2, 4, 8, 12
and 24 h, incubation plates were fixed with paraformaldehyde solution
(4%) and stained with FITC-labeled phalloidin (Dyomics, Germany), an
F-actin stain, and Hoechst (Invitrogen, USA), a nuclear stain. Images
were collected by using the InCell 1000 high-content system (GE Health-
care, USA). A total of ten fields per well were imaged under 10ꢂ magni-
fication by using three separate filters to capture the nucleus (blue; exci-
tation 345 nm, emission 435 nm), F-actin (green; excitation 475 nm, emis-
sion, 535 nm) and photosensitiser (red; excitation 535 nm, emission
620 nm). Image analysis was performed by using the InCell 1000 image
analyser with a dual-area object analysis algorithm for the determination
of intracellular photosensitiser intensity (average fluorescence intensity
of pixels within the cytoplasmic region of the red photosensitiser). The
image analysis software detects the nuclear area of the cells and the cell
number by nuclear-dye uptake; quantifications of cell morphologies and
PS parameters are determined by F-actin stain and Foscan. Stain parame-
ters, such as the morphology and intensity of fluorescence, were logged
numerically for individual cells in every field, as well as the averages for
each field and well.[41] Each experiment was repeated a minimum of
three times and results were normalised to untreated controls. Averages
and standard error of the mean (SEM) of each well were plotted by
using Graphpad Prism Version 5.0 (GraphPad Software, USA). Differen-
ces in the cell proliferation data were evaluated by two-way ANOVA
with Bonferroni comparison using Graphpad Prism Version 5.0.
[12] a) I. Laville, T. Figueiredo, B. Loock, S. Pigaglio, P. Maillard, D. S.
11, 1643–1652; b) S. K. Pandey, X. Zheng, J. Morgan, J. R. Missert,
T. H. Liu, M. Shibata, D. A. Bellnier, A. R. Oseroff, B. W. Hender-
[13] S. Thompson, X. Chen, L. Hui, A. Toschi, D. A. Foster, C. M. Drain,
Acknowledgements
This work was supported by grants from the School of Chemistry (TCD),
the Health Research Board (translational research award 2007 TRA/
2007/11), the Science Foundation Ireland (SFI P.I. 09/IN.1/B2650), the
Fundażo da CiÞncia
e Tecnologia (SFRH/BD/62364/2009) and the
3558–3559; b) X. Zheng, J. Morgan, S. K. Pandey, Y. Chen, E.
Tracy, H. Baumann, J. R. Missert, C. Batt, J. Jackson, D. A. Bellnier,
[15] a) A. Makky, J. P. Michel, A. Kasselouri, E. Briand, P. Maillard, V.
1808, 656–666; c) S. Ballut, D. Naud-Martin, B. Loock, P. Maillard,
J. Blais, F. Doz, L. Desjardins, D. Carrez, J. L. Guerquin-Kern, A.
Obata, H. Alitomo, K. Sharyo, S. I. Ogata, C. Ohtsuki, S. Yano, T.
Hirohara, M. Obata, H. Alitomo, K. Sharyo, T. Ando, M. Tanihara,
wal, S. Singh, Y. Zhang, M. Anthes, D. Samaroo, R. Gao, C. M.
IRCSET EMBARK Initiative.
mings, J. Esko, H. Freeze, G. W. Hart, J. Marth, Essentials of Glyco-
biology, Cold Spring Harbor Laboratory Press, New York, 1999;
Shukla, A. Tiwari, Crit. Rev. Ther. Drug Carrier Syst. 2011, 28, 255–
292; c) S. Y. Hong, G. Tobias, K. T. Al-Jamal, B. Ballesteros, H. Ali-
Boucetta, S. Lozano-Perez, P. D. Nellist, R. B. Sim, C. Finucane, S. J.
Mather, M. L. H. Green, K. Kostarelos, B. G. Davis, Nat. Mater.
Ofek, P. K. Johannis, Comprehensive Glycoscience (Ed.: Pk K. Jo-
hannis), Elsevier, Oxford, 2007, 623–659; c) E. Sverremark, C. Fer-
[17] H. P. Li, Z. Cao, H. W. Xiao, Med. Chem. Res. 2007, 17, 28–38.
[18] a) V. Sol, P. Branland, R. Granet, C. Kaldapa, B. Verneuil, P.
[4] a) S. Hakomori, R. Kannagi, J. Natl. Cancer Inst. 1983, 71, 231–251;
1996, 56, 2237–2244.
[5] a) M. Monsigny, A. C. Roche, C. Kieda, P. Midoux, A. Obrenovitch,
&
8
&
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 0000, 00, 0 – 0
ÝÝ
These are not the final page numbers!